748. Larsen J. P., Tandberg E. Sleep disorders in patients with Parkinson’s disease //CNS drugs. – 2001. – Т. 15. – №. 4. C. 267-275.
749. Juncos J. L. et al. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease //Movement Disorders. – 2004. – Т. 19. – №. 1. C. 29-35.
750. Mamikonyan E. et al. Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo‐controlled study //Movement Disorders. – 2015. – Т. 30. – №. 7. C. 912-918.
751. Nashatizadeh M.M, Lyons K.E., Pahwa R. A review of ropinirole prolonged release in Parkinson’s disease//Clin Interv Aging. 2009; 4: 179–186.
752. Crosby N.J., Deane K.H., Clarke C.E. Beta-blocker therapy for tremor in Parkinson's disease//Cochrane Database Syst Rev. 2003;(1):CD003361.
753. Jost W.H. Use of Botulinum Neurotoxin in Parkinson’s Disease: A Critical Appraisal// Toxins (Basel). 2021 Feb; 13(2): 87.
754. Batla A. et al. Treatment options for urogenital dysfunction in Parkinson’s disease //Current treatment options in neurology. – 2016. – Т. 18. – №. 10. C. 1-13.
755. Ondo W. G. et al. Memantine for non-motor features of Parkinson’s disease: a double-blind placebo controlled exploratory pilot trial //Parkinsonism & related disorders. – 2011. – Т. 17. – №. 3. C. 156-159.
756. Parkinson Study Group. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease //New England Journal of Medicine. – 1999. – Т. 340. – №. 10. C. 757-763.
757. Merims D. et al. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis //Clinical neuropharmacology. – 2006. – Т. 29. – №. 6. C. 331- 337.
758. Shvarts P. G. et al. Experience with application of trospium chloride in patients with neurogenic detrusor overactivity //Urologiia (Moscow, Russia: 1999). – 2009. – №. 5. C. 24-29.
759. Moro A. et al. Delusional misidentification syndrome and other unusual delusions in advanced Parkinson's disease //Parkinsonism & related disorders. – 2013. – Т. 19. – №. 8. C. 751-754.
760. Goldman J. G. Treatment of Dementia in Parkinson’s Disease //Therapy of Movement Disorders. – Humana, Cham, 2019. C. 99-102.
761. Aiken C. B. et al. Pramipexole in psychiatry: a systematic review of the literature //Journal of Clinical Psychiatry. – 2007. – Т. 68. – №. 8. C. 1230-1236.